Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/10/02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06/02/20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27/07/23 |
Norman LaFrance
CTO | Chief Tech/Sci/R&D Officer | 76 | 08/12/21 |
Russ Havranek
PRN | Corporate Officer/Principal | - | 01/01/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/10/02 |
Richard Hawkins
CHM | Chairman | 75 | 01/12/07 |
Robert Lenk
BRD | Director/Board Member | 75 | 01/03/20 |
J. Clowes
BRD | Director/Board Member | 70 | 01/03/20 |
Greg Petersen
BRD | Director/Board Member | 61 | 14/02/20 |
Director/Board Member | 64 | 01/01/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 4 354 641 | 4 214 074 ( 96,77 %) | 78 559 ( 1,804 %) | 96,77 % |
Coordinate società
Plus Therapeutics, Inc.
4200 Marathon Boulevard Suite 200
78756, Austin
+737 255 7194
http://www.plustherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+17,96% | 47,02 Mrd | |
+48,77% | 41,86 Mrd | |
+1,17% | 41,76 Mrd | |
-4,27% | 28,8 Mrd | |
+11,42% | 26,05 Mrd | |
-21,39% | 19,15 Mrd | |
+4,86% | 12,55 Mrd | |
+27,29% | 12,34 Mrd | |
-3,50% | 11,82 Mrd |